Available in two main classes—IgG (Fc)–targeting and IgG (Intact / H+L)–targeting—these affinity-purified antibodies demonstrate minimal species cross-reactivity with monkey serum proteins ...

Efgartigimod is an antibody fragment designed to reduce pathogenic immunoglobulin G (IgG) antibodies by binding to the neonatal Fc receptor and blocking the IgG recycling process. Efgartigimod is ...

VYVGART ® is first-and-only targeted IgG Fc-antibody fragment for CIDP; First novel mechanism of action for CIDP treatment in more than 30 years; CHMP positive opinion based on ADHERE data, the ...